ESR1 and breast cancer: The D538G mutation, in the H11-H12 loop of ERα−LBD, is observed in ∼20% of BC patients with AI-treated metastatic disease and causes the “lengthening” of the H11-H12 spring in ERα, conferring constitutive activity (Figure 5B).